Alcresta Therapeutics, Inc.
Biotechnology · Financial Services
2 legal entities
Facts
as of Nov 17, 2026By continuing to use this site, you consent to our use of cookies to personalize your experience and to analyze website traffic. Learn more in our privacy policy.
- Legal name
- Alcresta Therapeutics, Inc.
- Headquarters
- Newton, United States
- Founded
- 2011
- Employees
- 201-500estimated range
- Legal entities
- 2 in 1 countries
- Register numbers
- NAME alcresta therapeutics inc · EIN 452729951
- Official records
- SEC CIK 1673510
- Website
- alcresta.com
These are the key facts about Alcresta Therapeutics, Inc. on Alion as of Nov 17, 2026. Alcresta Therapeutics, Inc. is headquartered in Newton, United States. It was founded in 2011. It has raised $75.9M in 4 funding rounds. The latest round is Venture - Series Unknown of $10M, announced in 2020.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
Alcresta Therapeutics, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Newton United States | Headquarters | 0 |
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$75.9MTotal raised
Venture - Series UnknownLatest round
4Rounds and grants
Money by yearUSD, rounds and grants
Largest rounds and grants
$50.9M
$10M
$10M
$5M
Sources: funding announcements, grant and company registers
Milestones
Nov 3, 2025
Feb 28, 2020
Raised a round Venture round $10M · SEC Form D
Jan 14, 2019
Raised a round Venture round $5M · SEC Form D
2011
Founded
Each milestone is dated by its source: registers, filings, the press
Newsroom
Jan 232026
News · YahooFinance
Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced the publication of real-wor…
Nov 3, 20252025
Oct 6, 20252025
News · YahooFinance
Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products, today announced expansion of the company
Sources: the outlets named on each headline, each story once
